Ofatumumab (Kesimpta) for multiple sclerosis.
Med Lett Drugs Ther
; 62(1614): 203-205, 2020 12 28.
Article
in English
| MEDLINE | ID: covidwho-1031248
Keywords
Search on Google
Collection:
International databases
Database:
MEDLINE
Main subject:
Multiple Sclerosis, Relapsing-Remitting
/
Antibodies, Monoclonal, Humanized
Type of study:
Prognostic study
/
Randomized controlled trials
Topics:
Long Covid
Limits:
Humans
Country/Region as subject:
North America
Language:
English
Journal:
Med Lett Drugs Ther
Year:
2020
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS